Priothera cleared to begin Japanese arm of pivotal PIII with mocravimod for AML
28 Feb 2023 //
BIOSPACE
Priothera announces first patients enrolled in Phase 2b/3 study with mocravimod
23 Jan 2023 //
PR NEWSWIRE
Priothera - FDA and EMA Grant ODD to mocravimod for AML in HSCT
02 Mar 2022 //
PRNEWSWIRE